Tasly Hong Kong Pharmaceutical Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors
€5 million convertible bonds issued to European investors,
European investors have also provided written indication of strong interest for the potential of additional €25 million in similar convertible bonds, depending on future market conditions
PARIS, FRANCE / ACCESSWIRE / February 4, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the
Company ), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, today announced a financing of €11 million through the combination of a €6 million capital raise subscribed by two existing shareholders by way of issuance of new ordinary shares (the ....

United States , France General , Dassault Merieux , Alexandre Berda , Pierre Bastid , Jeffrey Freedman , Sukaina Virji , Mary Jane Elliott , Pierre Louis Germain , Alexandra Harrison , Peter Collum , Euronext Growth Stock Exchange , Rooney Partners , Tasly Hong Kong Pharmaceutical Ltd , Media Relations International , Consilium Strategic Communications , Board Of Directors The Company , New Shares , David Horn Solomon , Chief Executive , Chief Financial Officer , Chief Business Officer , General Shareholder Meeting , New Share , Issue Price , Convertible Bonds ,